Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Gb002, Inc., A Wholly Owned Subsidiary Of Gossamer Bio, Inc.

Clinical trials sponsored by Gb002, Inc., A Wholly Owned Subsidiary Of Gossamer Bio, Inc., explained in plain language.

Not yet finished but already full! 1
Sort by
  • Inhaled drug shows promise for Long-Term PAH control

    Disease control Ongoing

    This study looks at the long-term safety of an inhaled medication called GB002 for people with pulmonary arterial hypertension (PAH), a serious lung condition that makes it hard to breathe. Participants had already taken GB002 in an earlier study and will continue treatment while…

    Phase: PHASE2 • Sponsor: GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. • Aim: Disease control

    Last updated May 26, 2026 12:08 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space